Membrane technology for the future treatment of paper mill effluents: chances and challenges of further system closure.

The pressure on the European paper industry to further close its water circuits has increased significantly during the past decade. Since the technologies of the past can no longer meet the requirements of the future, new water treatment methods have become necessary. A constant rise in the interest in membrane technology expressed by the European paper industry confirms that in the future this method will evolve into a key technology for continued water savings. The publication provides an overview of current and future applications of membrane plants in the European paper industry. A range of technologies is briefly presented together with their advantages and drawbacks, and the economic potential of membrane use is discussed. Among other topics, the authors take a look at the utilization of membrane filtration for treating internal circulation water, partial flows containing coating colours, and biologically treated effluents. The technologies addressed include ultrafiltration, nanofiltration and membrane bioreactor technology. Possible recovery and treatment routes for the concentrates produced by the nanofiltration of biologically treated effluents are examined and evaluated.

Comparison of the endocrine effects of treated wastewaters from different paper mills by use of an in-vitro test with modified yeast cells.

As opposed to effluents from chemical pulp production, very little is known about the endocrine potential of papermaking effluents. To evaluate the endocrine potential of biologically treated effluents from the main grades produced in Germany (fine, graphic and packaging papers), 16 samples were studied by means of the Recombinant Yeast Estrogen Assay (R-YEA). 10 samples were tested positive; seven of them were effluents from recovered paper processing mills. Possible sources of endocrine disruptors in addition to wood components include papermaking chemicals, paper converting chemicals, if recovered paper is used, and/or detrimental substances introduced by impurities in these chemicals. Six of the above samples were subjected to individual substance analyses to detect endocrinologically active or potentially endocrinologically active substances. Even though phthalate compounds were detected in concentrations between 0.46 and 2.36 microg/L, only two of the six samples were tested positive in the R-YEA, because the test fails to adequately detect this compound's class. Despite this drawback, the R-YEA will be used for further studies because of the great variety of potential endocrine substances present in paper mill effluents. In particular, mechanical and recycled fibre pulps as well as the constituents of chemical additives must be investigated in more detail.

Modulation of the immunophenotype of ovarian cancer cells by N,N-dimethylformamide and transforming growth factor-beta 1.

Exposure of HOC-7 ovarian adenocarcinoma cells to regulators of cell differentiation caused inducer-dependent alterations of the antigenic pattern of the cells. Immunocytochemistry revealed that N,N-dimethylformamide (DMF) elevated the membrane staining for epidermal growth factor (EGF)-receptor and for desmoplakins I and II. DMF also stimulated cytoplasmic and surface labeling for CA 125 and the deposition of fibronectin into the extracellular matrix. Stimulation of fibronectin was also seen after addition of transforming growth factor (TGF)-beta 1. These responses were quantified using a fixed-cell, enzyme-linked immunosorbent assay (ELISA) and revealed that DMF dose-dependently induced expression of EGF-receptor, CA 125, fibronectin, and desmoplakins I and II. TGF-beta 1 stimulated fibronectin and desmoplakins I and II only. Production of EGF and TGF-alpha was not affected by these inducers. Immunocytochemistry, ELISA and Western blotting showed that both inducers caused down-regulation of myc oncoproteins. DMF was more effective in changing the immunophenotype of HOC-7 cells than TGF-beta 1. Desmoplakins I and II demonstrated elevated epithelial differentiation, whereas fibronectin indicated stimulation of extracellular matrix formation. Elevated EGF-receptor could not compensate for the growth inhibition induced by DMF. The expression of myc oncoproteins was inversely related to cell proliferation. CA 125, however, seems to be unrelated to cell growth.

Different propensity for spontaneous differentiation of cell clones isolated from the human ovarian surface epithelial cell line HOC-7.

Limiting dilution culture of cell fractions obtained by discontinuous density gradient centrifugation was used to establish six different cell clones from HOC-7 ovarian adenocarcinoma cells (D1-D3, N1-N3). Clones D1-D3 revealed a phenotype similar to that seen in parental cells exposed to differentiation inducers such as dimethyl sulfoxide (DMSO, 0.8% [v/v]). They were flattened, slowly growing cells (doubling times: 42-46 h). The cells developed long cytoplasmic extensions and adopted a complicated growth pattern. Fixed-cell enzyme-linked immunosorbent assay (ELISA) and Western blotting demonstrated that these cells contained high levels of epidermal growth factor-receptor (EGF-R), carbohydrate antigen 125 (CA 125), fibronectin and desmoplakin, but low levels of myc oncoproteins. However, untreated parental cells and clones N1-N3 were fast-growing (doubling times: 23-28 h), regularly shaped, polygonal cells ("cobblestone" monolayer) with low levels of EGF-R, CA 125, fibronectin and desmoplakin, but relatively higher amounts of myc oncoproteins. The similarity of the sublines to either untreated or inducer-treated parental cells indicated that clones D1-D3 represented spontaneously differentiated HOC-7 cells, whereas clones N1-N3 originated from less-differentiated cells. The features examined in this model cell system proved to be closely related to ovarian cancer cell proliferation and differentiation. The observation of a tumor-inherent propensity for spontaneous differentiation suggests that exogenous stimulation of existing differentiation pathways may represent an alternative approach for tackling the problem of growth control and differentiation in malignant tissues.

Comparative analysis of the effects of dimethyl sulfoxide and retinoic acid on the antigenic pattern of human ovarian adenocarcinoma cells.

HOC-7 malignant ovarian surface epithelial cells have been exposed to differentiation promoters like dimethyl sulfoxide (DMSO) and retinoic acid (RA) and the resulting cell phenotypes were characterized immunologically. Immunocytochemistry revealed that DMSO caused elevation of membrane-associated staining for epidermal growth factor-receptor (EGF-R) and for desmoplakins I and II (DPI+II). DMSO also stimulated cytoplasmic and surface labelling for CA 125 and extracellular deposition of fibronectin (FN). A fixed-cell ELISA system was used for quantification of these differentiation-like responses and revealed that DMSO efficiently induced expression of EGF-R, CA 125, FN and DPI+II in dose-dependent manner. Immunocytochemistry, ELISA and Western blotting additionally demonstrated that both DMSO and RA caused down-regulation of myc oncoproteins. Densitometer evaluation of electrophoresed proteins revealed a 50% DMSO- and a 25% RA-induced myc reduction. Apart from growth reduction, which was seen for both inducers, inhibition of myc gene expression was the only response of HOC-7 cells to RA-treatment. The extent of myc down-regulation seems, therefore, to be crucial for the initiation of maturational processes in the cells. Subsequent phenotypic differentiation of HOC-7 cells causes elevated levels of EGF-R, CA 125, FN and DPI+II. This cell model might be useful for the distinction between induced growth reduction and differentiation of ovarian cancer cells.